Astellas Pharma Inc. and Potenza Therapeutics, Inc., a biotechnology company developing a portfolio of immuno-oncology programs, today announced an exclusive research and development collaboration.
Vical Incorporated today announced that it has entered into a $4 million contract with the IPPOX Foundation to manufacture HIV-antigen plasmid DNA as a component of vaccine regimens to be evaluated in clinical trials for the prevention of HIV infection.
The Roche Group posted strong sales growth in the first three months in both divisions, with demand for oncology and immunology medicines driving growth in pharmaceuticals, and immunodiagnostics products driving growth in diagnostics.
What are the trends in thinking and tech advancements being highlighted at INTERPHEX? Advantage Business Media's Jeff Reinke talks with Russ Soma to get a day one wrap-up from the conference and find out what else is in store this week.
Marrone Bio Innovations, Inc., a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced the opening of its new greenhouse to facilitate and expand its research and product development capacity.
GW Pharmaceuticals announced today that it has initiated the second Phase 3 clinical trial of Epidiolex(R) (cannabidiol or CBD) for the treatment of Dravet syndrome, a rare and catastrophic treatment-resistant form of childhood epilepsy.
ESCMID warns that Europe may surpass one million deaths due to ineffective antibiotics by 2025.
ITT Corporation is showcasing its highly engineered valve technologies and solutions at Interphex, one of the world's largest trade shows for the biopharmaceutical industry.
For the first time, the company will also be presenting a polymer prefillable syringe for sensitive drugs – the new SCHOTT TopPac SD.
A startup company that’s found a unique niche in the exploding cannabis industry, Potbotics uses robotic technology to bring medical marijuana use into a new era of high-tech pharma.
The medical and recreational marijuana stores industry has reached new highs, riding a wave of legalization to become one of the fastest growing industries in the United States.
CBRE Group, Inc. announced today that they have been hired to sell Eli Lilly’s biomanufacturing plant in Vacaville, California.
Inovio Pharmaceuticals, Inc. announced today that it has initiated a phase I trial to evaluate Inovio's DNA immunotherapy in patients who are chronically infected with hepatitis B.
ELC Group, one of the fastest-growing providers of regulatory affairs services, today announces that it has been awarded a 1.5 million Euro contract by one of China’s biggest pharmaceutical companies.
The potential combination would result in a powerhouse of a generic drug developer competing against rivals such as Sun Pharma.